» Authors » Kazue Takai

Kazue Takai

Explore the profile of Kazue Takai including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 30
Citations 744
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Takai K
Biomedicines . 2024 Mar; 12(3). PMID: 38540266
TAFRO (thrombocytopenia, anasarca, fever, reticulin fibrosis of bone marrow/renal dysfunction, organomegaly) syndrome is a systemic inflammatory disorder of unknown etiology. It has been recognized as a subtype of idiopathic multicentric...
2.
Masaki Y, Ueda Y, Yanagisawa H, Arita K, Sakai T, Yamada K, et al.
Intern Med . 2022 May; 62(1):27-32. PMID: 35598998
TAFRO syndrome was first described in 2010, standing for thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly. Because the lymph node histopathology of TAFRO syndrome mimics idiopathic multicentric Castleman disease (iMCD),...
3.
Masaki Y, Arita K, Sakai T, Takai K, Aoki S, Kawabata H
Ann Hematol . 2022 Jan; 101(3):485-490. PMID: 35044513
Although Castleman disease was first described in 1956, this disease includes various conditions, including unicentric Castleman disease with hyaline vascular histology, human herpesvirus-8 (HHV-8) related multicentric Castleman disease, idiopathic multicentric...
4.
Kawabata H, Fujimoto S, Sakai T, Yanagisawa H, Kitawaki T, Nara K, et al.
Int J Hematol . 2021 Jun; 114(2):301-302. PMID: 34061294
No abstract available.
5.
Kawabata H, Fujimoto S, Sakai T, Yanagisawa H, Kitawaki T, Nara K, et al.
Int J Hematol . 2021 Apr; 114(2):179-188. PMID: 33929719
Objectives: To identify prognostic factors for TAFRO syndrome, a rare inflammatory disorder of unknown etiology characterized by thrombocytopenia, anasarca, fever, reticulin myelofibrosis, renal dysfunction, and organomegaly. Methods: Data of patients...
6.
Fujimoto S, Kawabata H, Sakai T, Yanagisawa H, Nishikori M, Nara K, et al.
Int J Hematol . 2020 Sep; 113(1):73-80. PMID: 32970275
TAFRO syndrome is a systemic inflammatory disorder of unknown etiology characterized by thrombocytopenia, anasarca, fever, reticulin myelofibrosis, renal dysfunction, and organomegaly. Mortality in patients with this syndrome is high; however,...
7.
Masaki Y, Kawabata H, Takai K, Tsukamoto N, Fujimoto S, Ishigaki Y, et al.
Int J Hematol . 2019 Nov; 111(1):155-158. PMID: 31782045
No abstract available.
8.
Masaki Y, Kawabata H, Fujimoto S, Kawano M, Iwaki N, Kotani T, et al.
J Clin Exp Hematop . 2019 Nov; 59(4):175-178. PMID: 31708515
Castleman disease is a polyclonal lymphoproliferative disease which is clinically classified into unicentric (UCD) and multicentric (MCD). TAFRO syndrome is a relatively new concept that partly overlaps with MCD. Due...
9.
Kurose N, Guo X, Shioya A, Mizutani K, Kumagai M, Fujimoto S, et al.
Pathol Res Pract . 2019 Jul; 215(10):152563. PMID: 31358479
Idiopathic multicentric Castleman disease (iMCD) is a systemic inflammatory disease of unknown etiology caused by hypercytokinemia. Recently, TAFRO (thrombocytopenia, anasarca, fever, renal failure or reticulin fibrosis, and organomegaly) syndrome has...
10.
Fujimoto S, Sakai T, Kawabata H, Kurose N, Yamada S, Takai K, et al.
Am J Hematol . 2019 Jun; 94(9):975-983. PMID: 31222819
Castleman disease (CD) is a rare lymphoproliferative disorder that can be unicentric or multicentric. Multicentric CD (MCD) is further subdivided into human herpesvirus type-8-associated, POEMS syndrome-associated, and idiopathic (iMCD). TAFRO...